- Service Name
Structural Genomics Consortium (SGC)
- Industry
Biotechnology, Drug Discovery, Structural Biology, Open Science
- Main Value Proposition
The SGC provides a collaborative platform for researchers to contribute to and access vital data and resources that accelerate drug discovery.
- Description
The SGC is a global public-private partnership focused on understanding the functions of all human proteins. It aims to accelerate drug discovery through open-access research and collaboration.
- Key Features
Protein Donation Program for large-scale screenings; Development of high-quality datasets for protein-small molecule binding; Open-access research with no restrictions on data use; Collaboration with the computational community to leverage AI in drug discovery
- Use Cases
Researchers contributing purified proteins for drug discovery; Utilizing high-quality datasets for academic and industrial research; Collaborating on AI-driven drug discovery projects
- Competitive advantages
Extensive network of global research sites and partnerships; Commitment to open-access research, making all data publicly available; Proven track record of fostering collaboration across sectors
- Strengths
The SGC has a strong foundation in structural biology, a vast repository of protein structures, and a commitment to advancing drug discovery through innovative methodologies.
- Positioning
The SGC positions itself as a leader in open science and collaborative research, aiming to transform drug discovery through shared knowledge and resources.
- Audience
Target users include academic researchers, industry scientists, and organizations involved in drug discovery and development.
- CTA
Find out more, Learn more about us, Sign up for our newsletter
- Tags
Open Science
Drug Discovery
Protein Research
Collaboration
- Tagline
Welcome to the Structural Genomics Consortium
- Tone of Voice
Collaborative, innovative, transparent
- Differentiation
The SGC uniquely combines public and private sector resources to create a comprehensive open science approach to drug discovery, focusing on human proteins and utilizing advanced technologies like AI.
- Brand Positioning
The SGC is recognized as a pioneering entity in the field of structural genomics, emphasizing transparency, collaboration, and innovation in drug discovery.
- Founded
2004-01-01